93 related articles for article (PubMed ID: 15015601)
1. Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells.
Lanza A; Tava A; Catalano M; Ragona L; Singuaroli I; Robustelli della Cuna FS; Robustelli della Cuna G
Anticancer Res; 2004; 24(1):227-33. PubMed ID: 15015601
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.
Wan XS; Hamilton TC; Ware JH; Donahue JJ; Kennedy AR
Nutr Cancer; 1998; 31(1):8-17. PubMed ID: 9682243
[TBL] [Abstract][Full Text] [Related]
4. Anticarcinogenic Bowman Birk inhibitor isolated from snail medic seeds (Medicago scutellata): solution structure and analysis of self-association behavior.
Catalano M; Ragona L; Molinari H; Tava A; Zetta L
Biochemistry; 2003 Mar; 42(10):2836-46. PubMed ID: 12627949
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the anticarcinogenic Bowman-Birk inhibitor from snail medic (Medicago scutellata) seeds complexed with bovine trypsin.
Capaldi S; Perduca M; Faggion B; Carrizo ME; Tava A; Ragona L; Monaco HL
J Struct Biol; 2007 Apr; 158(1):71-9. PubMed ID: 17142058
[TBL] [Abstract][Full Text] [Related]
6. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
Chen YW; Huang SC; Lin-Shiau SY; Lin JK
Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
Kennedy CW; Donahue JJ; Wan XS
Nutr Cancer; 1996; 26(2):209-17. PubMed ID: 8875558
[TBL] [Abstract][Full Text] [Related]
8. A trypsin inhibitor from snail medic seeds active against pest proteases.
Ceciliani F; Tava A; Iori R; Mortarino M; Odoardi M; Ronchi S
Phytochemistry; 1997 Feb; 44(3):393-8. PubMed ID: 9014368
[TBL] [Abstract][Full Text] [Related]
9. A combined treatment of HeLa cells with the farnesyl protein transferase inhibitor L-744,832 and cisplatin significantly increases the therapeutic effect as compared to cisplatin monotherapy.
Wesierska-Gadek J; Kramer MP; Schmid G
J Cell Biochem; 2008 May; 104(1):189-201. PubMed ID: 18022825
[TBL] [Abstract][Full Text] [Related]
10. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes.
Dittmann K; Virsik-Köpp P; Mayer C; Rave-Fränk M; Rodemann HP
Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
[TBL] [Abstract][Full Text] [Related]
12. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
13. In vitro combined effect of a new series of copper (II) complexes with cisplatin or epirubicin on human breast and cervical cancer cell lines.
Geromichalos GD; Katsoulos GA; Hadjikostas CC; Kortsaris AH; Kyriakidis DA
Drugs Exp Clin Res; 1998; 24(2):93-104. PubMed ID: 9675550
[TBL] [Abstract][Full Text] [Related]
14. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
Ware JH; Wan XS; Kennedy AR
Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
[TBL] [Abstract][Full Text] [Related]
15. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T
Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
[TBL] [Abstract][Full Text] [Related]
17. Imbibition of soybean seeds in warm water results in the release of copious amounts of Bowman-Birk protease inhibitor, a putative anticarcinogenic agent.
Palavalli MH; Natarajan SS; Wang TT; Krishnan HB
J Agric Food Chem; 2012 Mar; 60(12):3135-43. PubMed ID: 22372424
[TBL] [Abstract][Full Text] [Related]
18. A Bowman-Birk trypsin inhibitor with antiproliferative activity from Hokkaido large black soybeans.
Ho VS; Ng TB
J Pept Sci; 2008 Mar; 14(3):278-82. PubMed ID: 17880027
[TBL] [Abstract][Full Text] [Related]
19. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
[TBL] [Abstract][Full Text] [Related]
20. Protection against adverse biological effects induced by space radiation by the Bowman-Birk inhibitor and antioxidants.
Kennedy AR; Zhou Z; Donahue JJ; Ware JH
Radiat Res; 2006 Aug; 166(2):327-32. PubMed ID: 16881733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
